1. Home
  2. TEF vs STE Comparison

TEF vs STE Comparison

Compare TEF & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telefonica SA

TEF

Telefonica SA

N/A

Current Price

$4.05

Market Cap

23.3B

ML Signal

N/A

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

N/A

Current Price

$251.82

Market Cap

25.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TEF
STE
Founded
1924
1985
Country
Spain
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Industrial Specialties
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.3B
25.9B
IPO Year
1987
1992

Fundamental Metrics

Financial Performance
Metric
TEF
STE
Price
$4.05
$251.82
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
N/A
$268.25
AVG Volume (30 Days)
1.0M
631.7K
Earning Date
11-04-2025
02-04-2026
Dividend Yield
5.67%
1.00%
EPS Growth
N/A
59.39
EPS
N/A
6.97
Revenue
$48,832,570,697.00
$5,702,415,000.00
Revenue This Year
N/A
$9.61
Revenue Next Year
$0.09
$6.23
P/E Ratio
N/A
$36.29
Revenue Growth
2.59
7.08
52 Week Low
$3.89
$200.98
52 Week High
$5.72
$268.60

Technical Indicators

Market Signals
Indicator
TEF
STE
Relative Strength Index (RSI) 33.07 41.85
Support Level $4.13 $249.92
Resistance Level $4.31 $261.45
Average True Range (ATR) 0.06 4.88
MACD 0.02 -1.74
Stochastic Oscillator 34.44 7.02

Price Performance

Historical Comparison
TEF
STE

About TEF Telefonica SA

Telefonica is a telecom operator with presence in Spain (where it is the incumbent operator), the UK, Germany, Brazil, and Latin American countries. The company derives more than 30% of its revenue from Spain, close to 20% from Germany, and 20% from Brazil. Its UK operations are held through a joint venture with Virgin Media. For several years Telefonica has been simplifying its corporate structure by selling noncore assets.

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Share on Social Networks: